State Of Wisconsin Investment Board Morphic Holding, Inc. Transaction History

State Of Wisconsin Investment Board

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$26.12 - $34.07 $25,937 - $33,831	-993 Reduced 4.94%	19,105 $650,000
Q1 2024 May 14, 2024	SELL	$26.64 - $40.31 $66,306 - $100,331	-2,489 Reduced 11.02%	20,098 $707,000
Q4 2023 Feb 12, 2024	SELL	$19.95 - $31.0 $133,006 - $206,677	-6,667 Reduced 22.79%	22,587 $652,000
Q3 2023 Nov 14, 2023	SELL	$21.33 - $59.42 $103,215 - $287,533	-4,839 Reduced 14.19%	29,254 $670,000
Q2 2023 Aug 14, 2023	BUY	$34.33 - $62.11 $383,191 - $693,271	11,162 Added 48.68%	34,093 $1.95 Million
Q1 2023 May 15, 2023	BUY	$26.01 - $48.69 $85,598 - $160,238	3,291 Added 16.76%	22,931 $863,000
Q4 2022 Feb 14, 2023	SELL	$24.14 - $30.37 $31,116 - $39,146	-1,289 Reduced 6.16%	19,640 $525,000
Q3 2022 Nov 14, 2022	BUY	$22.23 - $33.37 $16,138 - $24,226	726 Added 3.59%	20,929 $592,000
Q2 2022 Aug 15, 2022	SELL	$19.74 - $43.01 $373,026 - $812,759	-18,897 Reduced 48.33%	20,203 $438,000
Q1 2022 May 13, 2022	BUY	$36.25 - $52.02 $239,250 - $343,332	6,600 Added 20.31%	39,100 $1.57 Million
Q2 2021 Aug 12, 2021	BUY	$45.13 - $64.99 $415,196 - $597,908	9,200 Added 39.48%	32,500 $1.87 Million
Q1 2021 May 17, 2021	BUY	$29.77 - $84.85 $113,126 - $322,430	3,800 Added 19.49%	23,300 $1.47 Million
Q4 2020 Feb 03, 2021	SELL	$25.66 - $34.55 $61,584 - $82,920	-2,400 Reduced 10.96%	19,500 $654,000
Q2 2020 Aug 12, 2020	BUY	$12.65 - $29.57 $68,310 - $159,678	5,400 Added 32.73%	21,900 $592,000
Q1 2020 May 06, 2020	BUY	$10.84 - $20.85 $178,860 - $344,025	16,500 New	16,500 $242,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.